Sleep-disordered breathing (SDB) describes a group of disorders in which partial or complete cessation of breathing occurs many times throughout the night, resulting in daytime sleepiness or fatigue that interferes with a person's ability to function and reduces quality of life. Transplantation has become an important treatment modality for end-stage organ failure. Transplant recipients are now living longer and, hence, develop chronic adverse medical conditions. Furthermore, transplantation is associated with weight gain. Despite the high prevalence of poor sleep and cardiovascular conditions among transplant patients, SDB is not well studied in these patients.
The primary research objective is to evaluate the prevalence, incidence and type (central or obstructive) of SDB in patients after lung transplantation. Secondary research objectives are the evaluation of correlations between severity of SDB and clinical findings (weight, medical therapy, heart function, lung function, renal function, graft failure, …). Furthermore, the investigators will evaluate the relationship between SDB and cardiovascular morbidity.
Study Type
OBSERVATIONAL
Enrollment
300
UZ Leuven
Leuven, Belgium
RECRUITINGNumber of participants with SDB and type (central or obstructive) of SDB
Prevalence of different types of SDB after lung transplantation
Time frame: 1 year after lung transplantation
Echocardiography
Correlations between SDB and heart function
Time frame: 1 year after lung transplantation
Lung function measurement
Correlations between SDB and lung function
Time frame: 1 year after lung transplantation
Blood analysis
Correlations between SDB and renal function
Time frame: 1 year after lung transplantation
24h blood pressure
Evaluation of relationship between hypertension and SDB
Time frame: 1 year after lung transplantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.